Injectable Semaglutide
In stock
View at Merchant
Semaglutide is used to activate the GLP-1 receptor, leading to increased insulin release, reduced glucagon secretion, slowed gastric emptying, decreased hunger, and reduced ghrelin levels.
- The description claims increased insulin release.
- The description claims reduced glucagon secretion.
- The description claims slowed gastric emptying and increased feelings of fullness.
- The description claims decreased hunger through satiety pathways.
- The description claims reduced ghrelin levels in the stomach/gut.
Variants (1)
- Default Title — 0.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
56%